696 related articles for article (PubMed ID: 8091823)
21. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
22. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
23. [Acute hemodynamic effects of piroximone i.v. in patients with severe heart failure].
Scholz M; Kneissl GD; Winkelmann BW; Grohe G; Klittich P; Bussmann WD
Z Kardiol; 1995 Oct; 84(10):827-33. PubMed ID: 7502570
[TBL] [Abstract][Full Text] [Related]
24. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
Di Mario C; Compostella L; Iavernaro A; Libardoni M; Ghirardi P; Cucchini F
Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
[TBL] [Abstract][Full Text] [Related]
25. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
[TBL] [Abstract][Full Text] [Related]
26. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
27. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
[TBL] [Abstract][Full Text] [Related]
28. [Acute effect of enoximone and captopril in patients with heart failure].
Scholz M; Kneissl GD; Dieterich HA; Kaltenbach M; Bussmann WD
Z Kardiol; 1991; 80 Suppl 4():69-74. PubMed ID: 1833901
[TBL] [Abstract][Full Text] [Related]
29. [Enoximone in postoperative "low-output syndrome"--comparison with dobutamine].
Orellano L; Darwisch M; Dieterich HA; Köllner V
Z Kardiol; 1991; 80 Suppl 4():53-7. PubMed ID: 1833898
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacodynamic effects of the phosphodiesterase inhibitor enoximone during exposure to the volatile anesthetics halothane and isoflurane in coronary surgery patients].
Molter G; Larsen R; Peters U; Bauch U; Sefrin R
Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Dec; 28(8):493-9. PubMed ID: 8292702
[TBL] [Abstract][Full Text] [Related]
31. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
Neuzner J; Mitrovic V; Pitschner HF; Lissmann H; Schlepper M
Z Kardiol; 1991 Jun; 80(6):397-403. PubMed ID: 1681628
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic and neurohumoral effects of ketanserin, a 5-HT2 receptor antagonist in patients with congestive heart failure.
Majid PA; Morris WM; Sole MJ
Can J Cardiol; 1987 Mar; 3(2):70-4. PubMed ID: 3567710
[TBL] [Abstract][Full Text] [Related]
33. [Hemodynamic effects of enoximone in patients with low left ventricular ejection fraction in surgery for ischemic heart disease].
Kakác J; Brezina A; Pirk J
Cor Vasa; 1993; 35(5):200-5. PubMed ID: 8258278
[TBL] [Abstract][Full Text] [Related]
34. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
[TBL] [Abstract][Full Text] [Related]
35. [The hemodynamic profile of the response to amrinone treatment in severe heart failure].
Domínguez de Rozas J; García Picart J; Guindo Soldevila J; Altimiras Ruiz J; Binia Mizrahi M; Pastor Ramón E; Bayés de Luna A
Rev Esp Cardiol; 1991 Apr; 44(4):226-32. PubMed ID: 2068366
[TBL] [Abstract][Full Text] [Related]
36. [Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
Mitrovic V; Schlepper M; Neuzner J; Bahavar H; Volz M; Dieterich HA
Z Kardiol; 1988 Oct; 77(10):660-7. PubMed ID: 2977029
[TBL] [Abstract][Full Text] [Related]
37. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
38. The hemodynamic effect of dopamine in children.
Driscoll DJ; Gillette PC; Duff DF; McNamara DG
J Thorac Cardiovasc Surg; 1979 Nov; 78(5):765-8. PubMed ID: 491732
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Baumann G; Ningel K; Permanetter B
J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
[TBL] [Abstract][Full Text] [Related]
40. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
Mager G; Klocke RK; Volkmann A; Kux A; Höpp HW; Hilger HH
Z Kardiol; 1991 Feb; 80(2):149-57. PubMed ID: 2058247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
